Literature DB >> 12966142

Candida albicans secreted aspartyl proteinases in virulence and pathogenesis.

Julian R Naglik1, Stephen J Challacombe, Bernhard Hube.   

Abstract

Candida albicans is the most common fungal pathogen of humans and has developed an extensive repertoire of putative virulence mechanisms that allows successful colonization and infection of the host under suitable predisposing conditions. Extracellular proteolytic activity plays a central role in Candida pathogenicity and is produced by a family of 10 secreted aspartyl proteinases (Sap proteins). Although the consequences of proteinase secretion during human infections is not precisely known, in vitro, animal, and human studies have implicated the proteinases in C. albicans virulence in one of the following seven ways: (i) correlation between Sap production in vitro and Candida virulence, (ii) degradation of human proteins and structural analysis in determining Sap substrate specificity, (iii) association of Sap production with other virulence processes of C. albicans, (iv) Sap protein production and Sap immune responses in animal and human infections, (v) SAP gene expression during Candida infections, (vi) modulation of C. albicans virulence by aspartyl proteinase inhibitors, and (vii) the use of SAP-disrupted mutants to analyze C. albicans virulence. Sap proteins fulfill a number of specialized functions during the infective process, which include the simple role of digesting molecules for nutrient acquisition, digesting or distorting host cell membranes to facilitate adhesion and tissue invasion, and digesting cells and molecules of the host immune system to avoid or resist antimicrobial attack by the host. We have critically discussed the data relevant to each of these seven criteria, with specific emphasis on how this proteinase family could contribute to Candida virulence and pathogenesis.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12966142      PMCID: PMC193873          DOI: 10.1128/MMBR.67.3.400-428.2003

Source DB:  PubMed          Journal:  Microbiol Mol Biol Rev        ISSN: 1092-2172            Impact factor:   11.056


  243 in total

1.  The histone deacetylase genes HDA1 and RPD3 play distinct roles in regulation of high-frequency phenotypic switching in Candida albicans.

Authors:  T Srikantha; L Tsai; K Daniels; A J Klar; D R Soll
Journal:  J Bacteriol       Date:  2001-08       Impact factor: 3.490

Review 2.  Candida albicans proteinases: resolving the mystery of a gene family.

Authors:  Bernhard Hube; Julian Naglik
Journal:  Microbiology       Date:  2001-08       Impact factor: 2.777

3.  Genomic profiling of the response of Candida albicans to itraconazole treatment using a DNA microarray.

Authors:  M D De Backer; T Ilyina; X J Ma; S Vandoninck; W H Luyten; H Vanden Bossche
Journal:  Antimicrob Agents Chemother       Date:  2001-06       Impact factor: 5.191

Review 4.  Candida proteases and their inhibition: prospects for antifungal therapy.

Authors:  K Stewart; C Abad-Zapatero
Journal:  Curr Med Chem       Date:  2001-07       Impact factor: 4.530

5.  Secreted aspartic proteases of Candida albicans, Candida tropicalis, Candida parapsilosis and Candida lusitaniae. Inhibition with peptidomimetic inhibitors.

Authors:  I Pichová; L Pavlícková; J Dostál; E Dolejsí; O Hrusková-Heidingsfeldová; J Weber; T Ruml; M Soucek
Journal:  Eur J Biochem       Date:  2001-05

Review 6.  Virulence factors of Candida albicans.

Authors:  R A Calderone; W A Fonzi
Journal:  Trends Microbiol       Date:  2001-07       Impact factor: 17.079

7.  HIV protease inhibitors attenuate adherence of Candida albicans to epithelial cells in vitro.

Authors:  J Bektić; C P Lell; A Fuchs; H Stoiber; C Speth; C Lass-Flörl; M Borg-von Zepelin; M P Dierich; R Würzner
Journal:  FEMS Immunol Med Microbiol       Date:  2001-07

8.  A histone deacetylation inhibitor and mutant promote colony-type switching of the human pathogen Candida albicans.

Authors:  A J Klar; T Srikantha; D R Soll
Journal:  Genetics       Date:  2001-06       Impact factor: 4.562

9.  Increased serum and salivary immunoglobulins against Candida albicans in HIV-infected patients with oral candidiasis.

Authors:  C Drobacheff; L Millon; M Monod; R Piarroux; E Robinet; R Laurent; D Meillet
Journal:  Clin Chem Lab Med       Date:  2001-06       Impact factor: 3.694

10.  NRG1 represses yeast-hypha morphogenesis and hypha-specific gene expression in Candida albicans.

Authors:  A M Murad; P Leng; M Straffon; J Wishart; S Macaskill; D MacCallum; N Schnell; D Talibi; D Marechal; F Tekaia; C d'Enfert; C Gaillardin; F C Odds; A J Brown
Journal:  EMBO J       Date:  2001-09-03       Impact factor: 11.598

View more
  336 in total

1.  Loss of heterozygosity at an unlinked genomic locus is responsible for the phenotype of a Candida albicans sap4Δ sap5Δ sap6Δ mutant.

Authors:  Nico Dunkel; Joachim Morschhäuser
Journal:  Eukaryot Cell       Date:  2010-11-19

2.  Proteolytic cleavage of covalently linked cell wall proteins by Candida albicans Sap9 and Sap10.

Authors:  Lydia Schild; Antje Heyken; Piet W J de Groot; Ekkehard Hiller; Marlen Mock; Chris de Koster; Uwe Horn; Steffen Rupp; Bernhard Hube
Journal:  Eukaryot Cell       Date:  2010-11-19

3.  Production of a novel and cold-active killer toxin by Mrakia frigida 2E00797 isolated from sea sediment in Antarctica.

Authors:  Ming-Xia Hua; Zhe Chi; Guang-Lei Liu; Muhammad Aslam Buzdar; Zhen-Ming Chi
Journal:  Extremophiles       Date:  2010-10-26       Impact factor: 2.395

4.  Deletion of the Candida albicans PIR32 results in increased virulence, stress response, and upregulation of cell wall chitin deposition.

Authors:  Wael Bahnan; Joseph Koussa; Samer Younes; Marybel Abi Rizk; Bassem Khalil; Sally El Sitt; Samer Hanna; Mirvat El-Sibai; Roy A Khalaf
Journal:  Mycopathologia       Date:  2012-03-06       Impact factor: 2.574

5.  Evidence for the presence of proteolytically active secreted aspartic proteinase 1 of Candida parapsilosis in the cell wall.

Authors:  Zuzana Vinterová; Miloslav Sanda; Jiří Dostál; Olga Hrušková-Heidingsfeldová; Iva Pichová
Journal:  Protein Sci       Date:  2011-11-01       Impact factor: 6.725

6.  In vitro Candida albicans biofilm induced proteinase activity and SAP8 expression correlates with in vivo denture stomatitis severity.

Authors:  Gordon Ramage; Brent Coco; Leighann Sherry; Jeremy Bagg; David F Lappin
Journal:  Mycopathologia       Date:  2012-07       Impact factor: 2.574

Review 7.  Candida albicans Pathogenesis: Fitting within the Host-Microbe Damage Response Framework.

Authors:  Mary Ann Jabra-Rizk; Eric F Kong; Christina Tsui; M Hong Nguyen; Cornelius J Clancy; Paul L Fidel; Mairi Noverr
Journal:  Infect Immun       Date:  2016-09-19       Impact factor: 3.441

8.  Rapid Phenotypic and Genotypic Diversification After Exposure to the Oral Host Niche in Candida albicans.

Authors:  Anja Forche; Gareth Cromie; Aleeza C Gerstein; Norma V Solis; Tippapha Pisithkul; Waracharee Srifa; Eric Jeffery; Darren Abbey; Scott G Filler; Aimée M Dudley; Judith Berman
Journal:  Genetics       Date:  2018-05-03       Impact factor: 4.562

9.  Susceptibility pattern of various azoles against Candida species causing vulvovaginal candidiasis.

Authors:  Preeti G Dharmik; A V Gomashe; V G Upadhyay
Journal:  J Obstet Gynaecol India       Date:  2012-11-02

10.  Quantitative expression of the Candida albicans secreted aspartyl proteinase gene family in human oral and vaginal candidiasis.

Authors:  Julian R Naglik; David Moyes; Jagruti Makwana; Priya Kanzaria; Elina Tsichlaki; Günther Weindl; Anwar R Tappuni; Catherine A Rodgers; Alexander J Woodman; Stephen J Challacombe; Martin Schaller; Bernhard Hube
Journal:  Microbiology (Reading)       Date:  2008-11       Impact factor: 2.777

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.